These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29699387)

  • 61. Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.
    Orfali N; O'Donovan TR; Nyhan MJ; Britschgi A; Tschan MP; Cahill MR; Mongan NP; Gudas LJ; McKenna SL
    Exp Hematol; 2015 Sep; 43(9):781-93.e2. PubMed ID: 25986473
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 63. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells.
    Mäntymaa P; Guttorm T; Siitonen T; Säily M; Savolainen ER; Levonen AL; Kinnula V; Koistinen P
    Haematologica; 2000 Mar; 85(3):238-45. PubMed ID: 10702810
    [TBL] [Abstract][Full Text] [Related]  

  • 65. All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.
    Belhabri A; Thomas X; Wattel E; Chelghoum Y; Anglaret B; Vekhoff A; Reman O; Dombret H; Dhedin N; Michallet M; Fière D; Archimbaud E
    Hematol J; 2002; 3(1):49-55. PubMed ID: 11960396
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17).
    Bullinger L; Schlenk RF; Götz M; Botzenhardt U; Hofmann S; Russ AC; Babiak A; Zhang L; Schneider V; Döhner K; Schmitt M; Döhner H; Greiner J
    Clin Cancer Res; 2013 May; 19(9):2562-71. PubMed ID: 23444226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biomodulatory Treatment With Azacitidine, All-
    Klobuch S; Steinberg T; Bruni E; Mirbeth C; Heilmeier B; Ghibelli L; Herr W; Reichle A; Thomas S
    Front Pharmacol; 2018; 9():1380. PubMed ID: 30542286
    [TBL] [Abstract][Full Text] [Related]  

  • 69. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML).
    Djamai H; Berrou J; Dupont M; Coudé MM; Delord M; Clappier E; Marceau-Renaut A; Kaci A; Raffoux E; Itzykson R; Berthier C; Wu HC; Hleihel R; Bazarbachi A; de Thé H; Baruchel A; Gardin C; Dombret H; Braun T
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
    Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
    Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
    Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
    Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
    [No Abstract]   [Full Text] [Related]  

  • 73. Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics.
    Sahoo RK; Kumar L; Kumar R; Sharma A
    Indian J Med Paediatr Oncol; 2013 Oct; 34(4):327-9. PubMed ID: 24604968
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X
    Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
    Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces
    Buschner G; Feuerecker B; Spinner S; Seidl C; Essler M
    Leuk Lymphoma; 2021 Mar; 62(3):630-639. PubMed ID: 33140666
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy.
    Martino OD; Welch JS
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805753
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements
    Yao J; Li G; Cui Z; Chen P; Wang J; Hu Z; Zhang L; Wei L
    Front Pharmacol; 2022; 13():876076. PubMed ID: 35571127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.